Intellia Therapeutics Inc buy Barclays PLC
Start price
04.08.23
/
50%
€36.00
Target price
04.08.24
€81.52
Performance (%)
-40.56%
Price
22:26
€21.40
Summary
This prediction is currently active. Massive losses of -40.56% have been the result for the BUY prediction by Barclays_PLC. This prediction currently runs until 04.08.24. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intellia Therapeutics Inc | -0.049% | -0.049% |
iShares Core DAX® | 0.383% | -1.593% |
iShares Nasdaq 100 | 1.543% | 7.530% |
iShares Nikkei 225® | 2.596% | 4.525% |
iShares S&P 500 | 0.573% | 4.229% |
Comments by Barclays_PLC for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Barclays PLC from $148.00 to $90.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat